Cargando…
Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes
OBJECTIVE(S): CD19 is a transmembrane glycoprotein of immunoglobulin superfamily. In order to treat lymphoma, monoclonal antibodies (mAb) can target different antigens, including CD19, CD20 and CD22 on the surface of B-cells. Along with biotechnology progress, a new generation of antibodies is intro...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mashhad University of Medical Sciences
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000210/ https://www.ncbi.nlm.nih.gov/pubmed/29922424 http://dx.doi.org/10.22038/IJBMS.2018.26778.6557 |